Literature DB >> 29134188

Simulation study of quantitative precision of the PET/X dedicated breast PET scanner.

Chengeng Zeng1, Paul E Kinahan1, Hua Qian2, Robert L Harrison1, Kyle M Champley3, Lawrence R MacDonald1.   

Abstract

The goal for positron emission tomography (PET)/X is measuring changes in radiotracer uptake for early assessment of response to breast cancer therapy. Upper bounds for detecting such changes were investigated using simulation and two image reconstruction algorithms customized to the PET/X rectangular geometry. Analytical reconstruction was used to study spatial resolution, comparing results with the distance of the closest approach (DCA) resolution surrogate that is independent of the reconstruction method. An iterative reconstruction algorithm was used to characterize contrast recovery in small targets. Resolution averaged [Formula: see text] full width at half maximum when using depth-of-interaction (DOI) information. Without DOI, resolution ranged from [Formula: see text] to [Formula: see text] for scanner crystal thickness between 5 and 15 mm. The DCA resolution surrogate was highly correlated to image-based FWHM. Receiver-operating characteristic analysis showed specificity and sensitivity over 95% for detecting contrast change from 5:1 to 4:1 (area under curve [Formula: see text]). For PET/X parameters modeled here, the ability to measure contrast changes benefited from higher photon absorption efficiency of thicker crystals while being largely unaffected by degraded resolution obtained with thicker crystals; DOI provided marginal improvements. These results assumed perfect data corrections and other idealizations, and thus represent an upper bound for detecting changes in small lesion radiotracer uptake of clinical interest using the PET/X system.

Entities:  

Keywords:  breast positron emission tomography; imaging biomarker; quantitative accuracy; response to therapy

Year:  2017        PMID: 29134188      PMCID: PMC5661484          DOI: 10.1117/1.JMI.4.4.045502

Source DB:  PubMed          Journal:  J Med Imaging (Bellingham)        ISSN: 2329-4302


  26 in total

1.  Design and evaluation of the MAMMI dedicated breast PET.

Authors:  L Moliner; A J Gonzalez; A Soriano; F Sanchez; C Correcher; A Orero; M Carles; L F Vidal; J Barbera; L Caballero; M Seimetz; C Vazquez; J M Benlloch
Journal:  Med Phys       Date:  2012-09       Impact factor: 4.071

2.  Performance Evaluation of a New Dedicated Breast PET Scanner Using NEMA NU4-2008 Standards.

Authors:  Kanae K Miyake; Keiichi Matsumoto; Mika Inoue; Yuji Nakamoto; Shotaro Kanao; Tae Oishi; Shigeto Kawase; Keishi Kitamura; Yoshiyuki Yamakawa; Ayako Akazawa; Tetsuya Kobayashi; Junichi Ohi; Kaori Togashi
Journal:  J Nucl Med       Date:  2014-05-08       Impact factor: 10.057

3.  Multiplexing strategies for monolithic crystal PET detector modules.

Authors:  L A Pierce; W C J Hunter; D R Haynor; L R MacDonald; P E Kinahan; R S Miyaoka
Journal:  Phys Med Biol       Date:  2014-08-22       Impact factor: 3.609

4.  Feasibility study for positron emission mammography.

Authors:  C J Thompson; K Murthy; I N Weinberg; F Mako
Journal:  Med Phys       Date:  1994-04       Impact factor: 4.071

5.  Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial.

Authors:  Bruno Coudert; Jean-Yves Pierga; Marie-Ange Mouret-Reynier; Kaldoun Kerrou; Jean-Marc Ferrero; Thierry Petit; Pierre Kerbrat; Pierre-François Dupré; Thomas Bachelot; Philippe Gabelle; Sylvia Giard; David Coeffic; Philippe Bougnoux; Jean-Briac Prevost; Gilles Paintaud; Gilles Thibault; Juana Hernandez; Mathieu Coudert; Laurent Arnould; Alina Berriolo-Riedinger
Journal:  Lancet Oncol       Date:  2014-10-30       Impact factor: 41.316

6.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Authors:  H Young; R Baum; U Cremerius; K Herholz; O Hoekstra; A A Lammertsma; J Pruim; P Price
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

7.  Design study of a high-resolution breast-dedicated PET system built from cadmium zinc telluride detectors.

Authors:  Hao Peng; Craig S Levin
Journal:  Phys Med Biol       Date:  2010-04-19       Impact factor: 3.609

8.  Quantification of radiotracer uptake with a dedicated breast PET imaging system.

Authors:  Raymond R Raylmana; Mark F Smith; Paul E Kinahan; Stan Majewski
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

9.  18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.

Authors:  Geraldine Gebhart; Cristina Gámez; Eileen Holmes; Javier Robles; Camilo Garcia; Montserrat Cortés; Evandro de Azambuja; Karine Fauria; Veerle Van Dooren; Gursel Aktan; Maria Antonia Coccia-Portugal; Sung-Bae Kim; Peter Vuylsteke; Hervé Cure; Holger Eidtmann; José Baselga; Martine Piccart; Patrick Flamen; Serena Di Cosimo
Journal:  J Nucl Med       Date:  2013-10-03       Impact factor: 10.057

10.  Impact of high energy resolution detectors on the performance of a PET system dedicated to breast cancer imaging.

Authors:  Craig S Levin; Angela M K Foudray; Frezghi Habte
Journal:  Phys Med       Date:  2006       Impact factor: 2.685

View more
  1 in total

1.  Impact of Using Uniform Attenuation Coefficients for Heterogeneously Dense Breasts in a Dedicated Breast PET/X-ray Scanner.

Authors:  Lawrence R MacDonald; Joseph Y Lo; Gregory M Sturgeon; Chengeng Zeng; Robert L Harrison; Paul E Kinahan; William Paul Segars
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2020-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.